Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Bimatoprost 300micrograms/ml / Timolol 5mg/ml eye drops
1106000AIAAAAAA
|
Timolol/bimatoprost | Timolol and bimatoprost | Eye | 117,534 |
|
Ganfort 0.3mg/ml / 5mg/ml eye drops
1106000AIBBAAAA
|
Ganfort | Timolol and bimatoprost | Eye | 74,766 |
|
Bimatoprost 300microg/Timolol 5mg/ml eye dps 0.4ml
1106000AIAAABAB
|
Timolol/bimatoprost | Timolol and bimatoprost | Eye | 35,368 |
|
Ganfort 0.3mg/ml / 5mg/ml eye drops 0.4ml unit dose
1106000AIBBABAB
|
Ganfort | Timolol and bimatoprost | Eye | 24,906 |
|
Bimatoprost 300microg / Timolol 5mg/ml eye dps preserv free
1106000AIAAACAC
|
Timolol/bimatoprost | Timolol and bimatoprost | Eye | 2,813 |
|
Eyzeetan 0.3mg/ml / 5mg/ml eye drops preservative free
1106000AIBCABAC
|
Eyzeetan | Timolol and bimatoprost | Eye | 496 |
|
Visublend 0.3mg/ml / 5mg/ml eye drops
1106000AIBDAAAA
|
Visublend | Timolol and bimatoprost | Eye | 223 |
|
Bimiduo 0.3mg/ml / 5mg/ml eye drops preservative free
1106000AIBEAAAC
|
Bimiduo | Timolol and bimatoprost | Eye | 9 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.